<Li> Prevnar 13 ( PCV13 ) is produced by Pfizer . It is a tridecavalent vaccine , meaning that it contains thirteen serotypes of pneumococcus ( 1 , 3 , 4 , 5 , 6A , 6B , 7F , 9V , 14 , 18C , 19A , 19F and 23F ) which are conjugated to diphtheria carrier protein . Prevnar 13 was approved by the U.S. Food and Drug Administration on February 24 , 2010 . After waiting for the outcome of a trial underway in the Netherlands , the Centers for Disease Control and Prevention ( CDC ) recommended the vaccine for adults over age 65 in August 2014 . </Li>
<Li> Prevnar 13 ( PCV13 ) is produced by Pfizer . It is a tridecavalent vaccine , meaning that it contains thirteen serotypes of pneumococcus ( 1 , 3 , 4 , 5 , 6A , 6B , 7F , 9V , 14 , 18C , 19A , 19F and 23F ) which are conjugated to diphtheria carrier protein . Prevnar 13 was approved by the U.S. Food and Drug Administration on February 24 , 2010 . After waiting for the outcome of a trial underway in the Netherlands , the Centers for Disease Control and Prevention ( CDC ) recommended the vaccine for adults over age 65 in August 2014 . </Li>
when did prevnar 13 come on the market
when did prevnar 13 come on the market
February 24 , 2010
February 24 , 2010